Clinical trial
Adnexal Mass After Methotrexate Treatment for Ectopic Pregnancies
NCT03138694 is registered in ClinicalTrials.gov with Tel-Aviv Sourasky Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adnexal Mass After Methotrexate Treatment for Ectopic Pregnancies
- Lead sponsor
- Tel-Aviv Sourasky Medical Center
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 31, 2017
- Completion date
- October 31, 2019
- Enrollment
- 500 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
ectopic pregnancies